Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion type Assertion NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_head.
- NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion description "[Specifically, 26 (96%) of 27 myxoid liposarcomas and its poorly differentiated variants showed a t(12;16); 29 (78%) of 37 atypical lipomatous tumors (including 5 dedifferentiated cases) showed ring chromosomes; 74 (80%) of 93 subcutaneous and intramuscular lipomas had karyotypic aberrations affecting mainly 12q, 6p, and 13q; 7 of 8 spindle cell and pleomorphic lipomas had aberrations of 16q; 3 lipoblastomas showed 8q rearrangements; and 2 hibernomas showed 11q abnormalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_provenance.
- NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion evidence source_evidence_literature NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_provenance.
- NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion SIO_000772 8579124 NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_provenance.
- NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion wasDerivedFrom befree-20140225 NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_provenance.
- NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_assertion wasGeneratedBy ECO_0000203 NP779309.RA5xHNYg2tvFlJfRyO5WPdrDp_6OYcIA-w_9hsMYE26-w130_provenance.